Helix BioPharma Corp Welcomes Drs. Daniel Von Hoff, Kazimierz Roszkowski-Sliz and Robert Gillies to Its Scientific and Strategic Advisory Board
March 22, 2018 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, March 22, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for...
Helix BioPharma Corp. Signs Collaboration Agreement With ProMab Biotechnologies to Co-Develop CAR-T for Hematological Malignancies
March 21, 2018 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, March 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP), (FSE:HBP) (“Helix” or the “Company”), a immuno-oncology company developing innovative drug candidates for...
Helix BioPharma Corp. Announces Fiscal Second Quarter 2018 Results
March 19, 2018 20:19 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, March 19, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative...
L-DOS47 US Phase I Study Presentation at the IASLC 18th Annual Target Therapies of Lung Cancer Meeting
February 23, 2018 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative...
Helix BioPharma Corp. Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities
February 22, 2018 17:00 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative...
Helix BioPharma Corp. Announces Fiscal First Quarter 2018 Results
December 13, 2017 17:27 ET
|
Helix BioPharma Corp.
RICHMOND HILL, ONTARIO--(Marketwired - Dec. 13, 2017) - Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP), an immuno-oncology company developing drug candidates for the prevention and...
Helix BioPharma Corp. Announces Voting Results From Annual and Special Meeting of Shareholders
December 12, 2017 17:24 ET
|
Helix BioPharma Corp.
RICHMOND HILL, ONTARIO--(Marketwired - Dec. 12, 2017) - Helix BioPharma Corp. (TSX:HPB)(FRANKFURT:HBP) ("Helix"), an immuno-oncology company developing drug candidates for the prevention...
Helix BioPharma Corp. Announces Management Change
December 01, 2017 17:05 ET
|
Helix BioPharma Corp.
RICHMOND HILL, ONTARIO--(Marketwired - Dec. 1, 2017) - Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP), an immuno-oncology company developing drug candidates for the prevention...
Helix BioPharma Corp. Announces Fiscal 2017 Year-End Results and Provides Research and Development Program Update
October 27, 2017 18:11 ET
|
Helix BioPharma Corp.
RICHMOND HILL, ONTARIO--(Marketwired - Oct. 27, 2017) - Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP), an immuno-oncology company developing drug candidates for the prevention and...
Helix BioPharma Corp. Closes Private Placement
October 19, 2017 16:48 ET
|
Helix BioPharma Corp.
RICHMOND HILL, ONTARIO--(Marketwired - Oct. 19, 2017) - Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug...